These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 17396037)

  • 1. Treatment of lupus nephritis with cyclosporine - an outcome analysis.
    Rihova Z; Vankova Z; Maixnerova D; Dostal C; Jancova E; Honsova E; Merta M; Rysava R; Tesar V
    Kidney Blood Press Res; 2007; 30(2):124-8. PubMed ID: 17396037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclosporine A in treatment of membranous lupus nephropathy.
    Hu W; Liu Z; Shen S; Li S; Yao X; Chen H; Li L
    Chin Med J (Engl); 2003 Dec; 116(12):1827-30. PubMed ID: 14687467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclosporine A or intravenous cyclophosphamide for lupus nephritis: the Cyclofa-Lune study.
    Zavada J; Pesickova S; Rysava R; Olejarova M; Horák P; Hrncír Z; Rychlík I; Havrda M; Vítova J; Lukác J; Rovensky J; Tegzova D; Böhmova J; Zadrazil J; Hána J; Dostál C; Tesar V
    Lupus; 2010 Oct; 19(11):1281-9. PubMed ID: 20605876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Withdrawal of therapy in patients with proliferative lupus nephritis: long-term follow-up.
    Moroni G; Gallelli B; Quaglini S; Banfi G; Rivolta E; Messa P; Ponticelli C
    Nephrol Dial Transplant; 2006 Jun; 21(6):1541-8. PubMed ID: 16455674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized pilot trial comparing cyclosporine and azathioprine for maintenance therapy in diffuse lupus nephritis over four years.
    Moroni G; Doria A; Mosca M; Alberighi OD; Ferraccioli G; Todesco S; Manno C; Altieri P; Ferrara R; Greco S; Ponticelli C
    Clin J Am Soc Nephrol; 2006 Sep; 1(5):925-32. PubMed ID: 17699309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of cyclosporine A in patients with refractory systemic lupus erythematosus in a daily clinical practice.
    Ogawa H; Kameda H; Amano K; Takeuchi T
    Lupus; 2010 Feb; 19(2):162-9. PubMed ID: 19952069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment and renal outcome of lupus nephritis: single center experience.
    Go KW; Teo SM
    Med J Malaysia; 2006 Oct; 61(4):447-50. PubMed ID: 17243522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of cyclosporine A on serum and urinary soluble interleukin-2 receptor in patients with lupus nephritis.
    Tang Z; Zhang J; Zhang S; Li L
    Chin Med J (Engl); 1997 Sep; 110(9):686-9. PubMed ID: 9642325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment with cyclophosphamide delays the progression of chronic lesions more effectively than does treatment with azathioprine plus methylprednisolone in patients with proliferative lupus nephritis.
    Grootscholten C; Bajema IM; Florquin S; Steenbergen EJ; Peutz-Kootstra CJ; Goldschmeding R; Bijl M; Hagen EC; Van Houwelingen HC; Derksen RH; Berden JH;
    Arthritis Rheum; 2007 Mar; 56(3):924-37. PubMed ID: 17328070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low dose cyclosporine A in the treatment of resistant proliferative lupus nephritis.
    Sheikholeslami M; Hajialilo M; Rasi Hashemi SS; Malek Mahdavi A; Gojazadeh M; Khabbazi A
    Mod Rheumatol; 2018 May; 28(3):523-529. PubMed ID: 28753077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determinants of renal functional outcome in lupus nephritis: a single centre retrospective study.
    Chrysochou C; Randhawa H; Reeve R; Waldek S; Wood GN; O'Donoghue DJ; Kalra PA
    QJM; 2008 Apr; 101(4):313-6. PubMed ID: 18270227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histopathologic and clinical outcome of rituximab treatment in patients with cyclophosphamide-resistant proliferative lupus nephritis.
    Gunnarsson I; Sundelin B; Jónsdóttir T; Jacobson SH; Henriksson EW; van Vollenhoven RF
    Arthritis Rheum; 2007 Apr; 56(4):1263-72. PubMed ID: 17393458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of tacrolimus versus cyclosporine in children with steroid-resistant nephrotic syndrome: a randomized controlled trial.
    Choudhry S; Bagga A; Hari P; Sharma S; Kalaivani M; Dinda A
    Am J Kidney Dis; 2009 May; 53(5):760-9. PubMed ID: 19268410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical assessment of tacrolimus therapy in lupus nephritis: one-year follow-up study in a single center.
    Asamiya Y; Uchida K; Otsubo S; Takei T; Nitta K
    Nephron Clin Pract; 2009; 113(4):c330-6. PubMed ID: 19729969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of enteric-coated mycophenolate sodium in patients with active lupus nephritis.
    Mak SK; Lo KY; Lo MW; Chan SF; Tong GM; Wong PN; Wong AK
    Nephrology (Carlton); 2008 Jun; 13(4):331-6. PubMed ID: 18476916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclosporine (CsA) in lupus nephritis: assessing the evidence.
    Moroni G; Doria A; Ponticelli C
    Nephrol Dial Transplant; 2009 Jan; 24(1):15-20. PubMed ID: 18852191
    [No Abstract]   [Full Text] [Related]  

  • 17. Induction treatment of proliferative lupus nephritis with leflunomide combined with prednisone: a prospective multi-centre observational study.
    Wang HY; Cui TG; Hou FF; Ni ZH; Chen XM; Lu FM; Xu FF; Yu XQ; Zhang FS; Zhao XZ; Zhao MH; Wang GB; Qian JQ; Cai GY; Zhu TY; Wang YH; Jiang ZP; Li YN; Mei CL; Zou WZ;
    Lupus; 2008 Jul; 17(7):638-44. PubMed ID: 18625636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tacrolimus for the treatment of systemic lupus erythematosus with pure class V nephritis.
    Szeto CC; Kwan BC; Lai FM; Tam LS; Li EK; Chow KM; Gang W; Li PK
    Rheumatology (Oxford); 2008 Nov; 47(11):1678-81. PubMed ID: 18753192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclosporine in the treatment of lupus nephritis including two patients treated during pregnancy.
    Hussein MM; Mooij JM; Roujouleh H
    Clin Nephrol; 1993 Sep; 40(3):160-3. PubMed ID: 8403571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The long-term outcome of 93 patients with proliferative lupus nephritis.
    Moroni G; Quaglini S; Gallelli B; Banfi G; Messa P; Ponticelli C
    Nephrol Dial Transplant; 2007 Sep; 22(9):2531-9. PubMed ID: 17510096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.